Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Neurogene Inc shares valued at $103,003 were sold by Cobb Stuart on May 14 ’25. At $15.15 per share, Cobb Stuart sold 6,797 shares. The insider’s holdings dropped to 20,794 shares worth approximately $0.4 million following the completion of this transaction.
Also, STUART COBB purchased 6,797 shares, netting a total of over 105,421 in proceeds.
Before that, Cvijic Christine Mikail had sold 4,501 shares from its account. In a trade valued at $76,247, the President and CFO traded Neurogene Inc shares for $16.94 each. Upon closing the transaction, the insider’s holdings decreased to 4,501 shares, worth approximately $1.4 million.
As published in their initiating research note from BMO Capital Markets on June 27, 2024, Neurogene Inc [NGNE] has been an Outperform and the price target has been revised to $65. Analysts at Robert W. Baird started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid June. As of April 29, 2024, Leerink Partners has initiated its “an Outperform” rating for NGNE. Earlier on March 21, 2024, William Blair initiated its rating. Their recommendation was “an Outperform” for NGNE stock.
Analyzing NGNE Stock Performance
During the last five days, there has been a surge of approximately 29.13%. Over the course of the year, Neurogene Inc shares have dropped approximately -15.27%. Shares of the company reached a 52-week high of $26.48 on 02/06/25 and a 52-week low of $6.88 on 04/08/25. A 50-day SMA is recorded $13.95, while a 200-day SMA reached $27.47.
Support And Resistance Levels for Neurogene Inc (NGNE)
According to the 24-hour chart, there is a support level at 16.31, which, if violated, would cause prices to drop to 13.25. In the upper region, resistance lies at 20.97. The next price resistance is at 22.57. RSI (Relative Strength Index) is 63.14 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.38, which suggests the price will increase in the coming days. Percent R is at 1.81%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Neurogene Inc (NGNE)?
On January 08, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $45.
